CUSIP: 046513206 | NYSE | Healthcare · Biotechnology | Micro Cap | 77 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13D/ARedmile Group, LLC with Redmile Biopharma Investments II, L.P., Redmile Strategic Long Only Trading Sub, Ltd. | 950,994 | 9.9% | Unchanged | Jul 22, 2026 | 441,701 sh (Jun 30, 2026) |
| 13G/APoint72 Asset Management, L.P. |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 176,758 | $1.5M | 0.0% | Core | Medium | Toronto Ontario, Australia | 2026-11-02 | |
| 80,950 | $688.4K | 0.0% | Index | Very Low | Boston, MA | 2026-11-06 | |
| 50,000 | $425.0K | 0.0% | Value | Low | Pittsburgh, PA | 2026-11-06 | |
| 1,404 | $11.9K | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2026-10-22 | |
| 266 | $2.3K | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 | |
| 214 | $1.8K | 0.0% | Core | Medium | London, United Kingdom | 2026-11-06 | |
| 1 | $8 | 0.0% | Growth | Low | Tampa, FL | 2026-10-16 | |
| 1 | $9 | 0.0% | Core | Medium | New York, NY | 2026-11-04 |
| 687,718 |
| 7.6% |
| New 5%+ stake |
| Jun 30, 2026 |
| No 13F filer matched |